Phase II study of three dose levels of continuous erythropoietin receptor activator (C. E. R. A.) in anaemic patients with aggressive non-Hodgkin's lymphoma receiving combination chemotherapy
収録刊行物
-
- Br J Hematol.
-
Br J Hematol. 136 736-744, 2007